picrorhiza kurroa – Ayurved Healing

Katuki (Picrorhiza kurroa): The Bitter Liver Protector You Need to Know

Rohan Kapoor — Wed, 01 Apr 2026 07:30:00 +0000

In Ayurveda, Katuki is not a casual “detox” herb. It is a sharp, bitter, practitioner-level medicine traditionally used when heat, bile, poor appetite, feverishness, jaundice-type presentation, and sluggish liver-digestive function are part of the picture. The liver itself is central to metabolism: it receives a large blood flow, produces bile needed for fat digestion, stores glucose as glycogen, and carries out major detoxification and drug-biotransformation work. That is why classical Ayurvedic liver care never treats Katuki as a lifestyle supplement; it is potent, useful, and best handled with respect.

What Is Katuki? The Bitter Rhizome From the Himalayas

Katuki, also written as Katuka, Kutki, Tikta, and Tiktarohini, is the dried rhizome with root of Picrorhiza kurroa Royle ex Benth. The Ayurvedic Pharmacopoeia of India describes it as a perennial Himalayan herb found from Kashmir to Sikkim, with a greyish-brown rhizome and a distinctly bitter taste. In practical Ayurvedic use, the rhizome-root portion is the medicinal part, and its bitterness is one of the most recognizable features of the drug.

Classical Ayurvedic Profile of Katuki

The Ayurvedic Pharmacopoeia of India gives Katuki the following profile: rasa is katu and tikta (pungent and bitter), guna is laghu (light), virya is ushna (hot), and vipaka is katu (pungent post-digestive effect). Its listed actions include hridya, pittahara, dipani, bhedini, and jvarahara. This corrects a common oversimplification: Katuki is bitter and Pitta-reducing in action, but its classical virya is not cooling; it is ushna.

Traditional Uses: Why Katuki Is Linked With the Liver

Classically, Katuki is listed for kamala (jaundice), jvara (fever), daha (burning sensation), kushtha (skin disorders), vishamajvara (irregular or intermittent fever), arocaka (loss of taste or appetite), and shvasa (breathing difficulty). Its dipani action supports appetite and digestive fire, while its bhedini action explains why it can loosen the bowels when overused or used in sensitive people. In liver-related presentations, this makes Katuki especially relevant when Pitta, bile disturbance, poor appetite, feverishness, and skin or eye discoloration are part of the clinical pattern.

The Pitta-Liver Connection in Ayurveda

Ayurvedic physiology connects the liver and spleen with Ranjaka Pitta, the transforming principle associated with the coloration and formation of Rakta Dhatu. Classical discussions differ in the exact seat emphasized, with some traditions emphasizing yakrit and pliha and others also discussing amashaya. For clinical purposes, the important point is that heat, bile, blood coloration, appetite, and liver-spleen function are traditionally understood as closely linked, which is why bitter and Pitta-regulating herbs such as Katuki are used with care in these patterns.

Bioactive Compounds in Katuki

Modern phytochemical descriptions identify iridoid glycosides as important constituents of Picrorhiza kurroa, especially picroside I, picroside II, kutkoside, and the mixture often called kutkin or picroliv. Other constituents reported from the plant include apocynin and cucurbitacin glycosides. These compounds help explain why Katuki has attracted attention for liver protection, antioxidant activity, bile-flow support, and inflammation-modulating effects in preclinical models.

What Has Been Documented for Liver Support

Human clinical work on Katuki is limited but notable. In a small randomized, double-blind, placebo-controlled trial in acute viral hepatitis, Picrorhiza kurroa root powder was given at 375 mg three times daily for two weeks; bilirubin, SGOT, and SGPT values improved more favorably in the Katuki group than in the placebo group. This is encouraging, but it does not make Katuki a replacement for diagnosis, monitoring, antiviral care when needed, or emergency treatment in severe liver disease.

Acute Hepatitis and Jaundice-Type Presentations

Katuki’s classical listing for kamala aligns with its use in jaundice-type presentations under medical supervision. In such cases, it should not be taken casually at home, because jaundice can arise from viral hepatitis, bile obstruction, hemolysis, drug injury, gallstones, autoimmune disease, or other causes that require medical evaluation.

Fatty Liver and Metabolic Liver Stress

Fatty liver disease is now a major global health issue, with recent estimates placing global NAFLD prevalence near one-third of adults. In experimental NAFLD models, standardized Picrorhiza kurroa extracts have been used to reduce liver fat accumulation and improve liver-related biochemical markers in animals. In Ayurveda, this fits a pattern where Kapha-Meda accumulation and Pitta disturbance both need attention: Katuki may be one part of care, but diet, weight management, movement, blood sugar control, and professional monitoring remain central.

Drug- and Toxin-Related Liver Stress

Preclinical work has examined Picrorhiza kurroa and picroliv in models of paracetamol or acetaminophen-related liver injury, alcohol-related oxidative stress, antitubercular-drug-related liver stress, and chemically induced cholestasis. These findings support Katuki’s traditional reputation as a liver-support herb, but they do not justify self-treating overdose, poisoning, medication-related liver injury, or abnormal liver enzymes without urgent medical care.

Bile Flow and Digestive Fire

Katuki’s Ayurvedic profile as dipani and bhedini matches its traditional use when appetite is low, bile movement is sluggish, and the stool needs downward regulation. Picroliv has also demonstrated choleretic action in animal models, which helps explain why Katuki is often chosen when bile flow and Pitta-liver patterns are clinically relevant. This same sharpness is why excessive or unsuitable use can lead to loose stools, cramping, nausea, or depletion.

Ayurvedic Formulations Containing Katuki

Katuki appears in several classical formulations rather than only as a single herb. This is important because formulations can moderate, direct, or broaden the action of a strong drug. The Ayurvedic Pharmacopoeia of India lists Katuki in preparations such as Arogyavardhini Gutika, Tiktaka Ghrita, Sarvajvarahara Lauha, and Mahatiktaka Ghrita.

Formulation	Why Katuki Is Relevant	Typical Clinical Context	Important Caution
Arogyavardhini Gutika	Uses Katuki in a broader liver-digestive formulation	Practitioner-directed liver, skin, digestion, and metabolic patterns	Do not self-prescribe, especially because classical versions may be herbo-mineral
Tiktaka Ghrita	Places Katuki within a bitter medicated ghee framework	Pitta-related skin and internal heat patterns	Use depends on digestion, strength, and suitability for ghee
Mahatiktaka Ghrita	Uses bitter herbs in a stronger ghee preparation	More intense Pitta-skin and heat patterns under supervision	Not suitable for every fatty liver or Kapha-heavy case
Sarvajvarahara Lauha	Includes Katuki in a fever-oriented formulation	Practitioner-selected fever and systemic patterns	Requires professional selection and dose control

How Katuki Is Traditionally Taken

The Ayurvedic Pharmacopoeia of India lists the powder dose of Katuki as 1-3 g. In real practice, dose, timing, vehicle, and duration are chosen according to constitution, bowel tendency, appetite, liver markers, diagnosis, age, strength, pregnancy status, and medications. Because Katuki is bhedini and intensely bitter, many practitioners begin conservatively and adjust only after assessing tolerance.

Diet During Katuki-Based Liver Care

Katuki works best when the diet does not keep provoking the same liver-digestive pattern. During practitioner-guided Katuki therapy, the usual Ayurvedic direction is to simplify food: avoid alcohol, heavy fried foods, excess oil, overeating, and very spicy meals; emphasize warm cooked food, mung dal, simple grains, cooked bitter vegetables, adequate hydration, and regular meal timing. When fatty liver, diabetes, high triglycerides, or obesity are present, the plan should also address weight, blood sugar, sleep, and movement.

Conservation and Ethical Sourcing

Picrorhiza kurroa is a threatened Himalayan medicinal plant, and recent conservation listings treat it as endangered. It is also listed in CITES Appendix II, meaning international trade is controlled to reduce pressure on wild populations. Responsible use means buying from suppliers who can document legal, cultivated, or sustainably managed sourcing, and avoiding casual overuse of a slow-growing alpine herb.

Safety and Contraindications

Katuki is powerful, bitter, and bowel-moving. It should be used carefully in thin, depleted, very dry, weak, elderly, or diarrhea-prone people. Reported adverse effects of picrorhiza products include digestive upset such as vomiting, anorexia, diarrhea, and itching or rash in some people. Avoid use during pregnancy and breastfeeding unless a qualified clinician specifically supervises it, because reliable safety data are insufficient.

Do not use Katuki to self-treat jaundice, hepatitis, severe abdominal pain, pale stools, dark urine, unexplained itching, or high liver enzymes.
Seek medical care urgently for suspected paracetamol/acetaminophen overdose or drug-induced liver injury.
Use caution with diabetes medications, as picrorhiza may affect blood sugar in some people.
Use caution in autoimmune conditions or while taking immunosuppressant drugs, because immune effects have been described.
Stop before surgery only under medical guidance, and tell your healthcare provider about all herbs and supplements.
Use only quality-tested products, especially when taking classical herbo-mineral formulations.

Practical takeaway: Katuki is one of Ayurveda’s strongest liver-digestive bitters, especially suited to selected Pitta-Kapha liver patterns involving poor appetite, heat, bile disturbance, jaundice-type presentation, skin involvement, and metabolic congestion. Used correctly, it can be a valuable part of Ayurvedic liver care. Used casually, in the wrong person, at the wrong dose, or without diagnosis, it can create problems or delay needed treatment.

This article is educational and does not constitute medical advice. Liver conditions require diagnosis and monitoring by qualified healthcare providers. Consult a qualified Ayurvedic practitioner and a licensed healthcare provider before using Katuki, especially if you have liver disease, abnormal liver tests, pregnancy, breastfeeding, diabetes, autoimmune disease, or take prescription medication. Never discontinue prescribed medication without medical guidance.

References

Kutki: The Liver Herb Western Medicine Is Finally Studying

Dr. Meera Iyer — Sat, 21 Feb 2026 16:45:53 +0000

Kutki, the Hindi name commonly used for Ayurvedic Kaṭukā (Picrorhiza kurroa Royle ex Benth.), is a bitter Himalayan perennial whose dried rhizome with attached root is an official Ayurvedic drug. Modern pharmacological interest centres on iridoid glycosides and on picroliv, a standardized fraction prepared from the underground parts. Its traditional importance is well established, but its modern clinical evidence is much smaller than the promotional language surrounding many “liver detox” products suggests.

What Makes Kutki Different From Other “Liver Herbs”

Kutki should not be treated as an Ayurvedic version of milk thistle. The two plants contain different chemical groups, have different traditions of use and have not been shown to be interchangeable. Kutki contains picrosides, kutkoside and other constituents such as apocynin and androsin. Picroliv is generally described as a fraction rich in picroside I and kutkoside; it is not identical to crude Kutki powder or to every commercial “standardized extract.”

Bile-related effects: Picroliv increased bile flow and bile constituents and opposed experimentally induced cholestasis in rats and other laboratory animals. This was a preclinical finding, not proof that Kutki treats human biliary disease or supports a defined “Phase II detoxification” pathway.
Antioxidant activity: Picroliv, picroside I and kutkoside scavenged superoxide anions in laboratory experiments. Animal models also report protection against several chemically induced forms of liver injury.
Metabolic liver models: Standardized extracts have been investigated in high-fat-diet models, and a 2025 picroside-rich fraction reduced steatohepatitis-related changes in zebrafish and mice. These results establish experimental activity, not clinical effectiveness.
Multiple preparations: Whole rhizome powder, aqueous or alcoholic extracts and picroliv differ in composition and dose. Findings from one preparation cannot automatically be assigned to another.

What the Evidence Actually Shows

The best-known published human trial is an older, small study in acute viral hepatitis. Much of the mechanistic literature comes from cell or animal experiments. The evidence supports continued investigation, but not the replacement of antiviral treatment, metabolic care or specialist management of chronic liver disease.

Study	Design	Finding	Interpretation
Vaidya et al., 1996	Randomized double-blind placebo-controlled trial; 33 HBsAg-negative patients with acute viral hepatitis	Root powder 375 mg three times daily for two weeks was associated with lower bilirubin and transaminase values and a shorter time to bilirubin reduction than placebo	Preliminary human evidence from a small, older study
Shukla et al., 1991	Animal pharmacology	Picroliv produced dose-dependent choleretic and anticholestatic effects	Does not establish a human treatment dose
Chander et al., 1992	Laboratory antioxidant study	Picroliv, picroside I and kutkoside scavenged superoxide anions	Mechanistic support only
Shetty et al., 2010	High-fat-diet rat model	Standardized extracts were assessed for reversal of fatty-liver changes	Experimental NAFLD study, not a clinical trial
Katoch et al., 2025	Zebrafish and mouse models of steatohepatitis	A picroside-rich fraction reduced lipid accumulation, inflammation and fibrosis-related changes	Recent preclinical evidence

Human trials have not established Kutki as a stand-alone treatment for chronic hepatitis, fibrosis, cirrhosis, drug-induced liver injury or metabolic fatty liver disease.

Kutki in the Ayurvedic Pharmacopoeia

The Ayurvedic Pharmacopoeia of India gives Kutki katu and tikta rasa (pungent and bitter tastes), laghu guṇa (light quality), śīta vīrya (cooling potency) and katu vipāka (pungent post-digestive effect). Its listed actions are hṛdya, pittahara, dīpanī, bhedinī and jvarahara. Listed therapeutic uses include śvāsa, dāha, jvara, kāmalā, kuṣṭha, viṣamajvara and arocaka.

The pharmacopoeial profile is not simply “bitter and cooling”: it also includes katu rasa alongside the śīta vīrya. The monograph identifies the dried rhizome with root as the drug and lists Ārogyavardhinī Guṭikā, Tiktaka Ghṛta, Sarvajvarahara Lauha and Mahātiktaka Ghṛta among important formulations. Classical terms such as kāmalā should be interpreted within Ayurvedic diagnosis; they are not automatic synonyms for every modern cause of jaundice or liver-enzyme elevation.

Whole Herb, Extract and Classical Formulation

Crude Kutki powder retains a broad plant matrix, whereas standardized fractions are manufactured to control selected markers. That distinction improves reproducibility in trials but also means that milligram doses are not interchangeable. A capsule labelled only “Kutki extract” is incomplete unless it states the botanical identity, plant part, extraction ratio or marker specification and manufacturer quality controls.

Ārogyavardhinī is a separate multi-ingredient herbo-mineral medicine, not simply a higher dose of Kutki. Traditional versions may contain processed mercury, sulfur, copper, iron and mica ingredients along with herbs. It should therefore be obtained from a properly licensed source and used only under qualified Ayurvedic supervision rather than self-prescribed from an unverified online formula.

Dosing: What Can Be Stated Reliably

The Ayurvedic Pharmacopoeia gives a dose of 1–3 g of the drug in powder form. Health Canada’s current adult monograph likewise specifies 1–3 g daily of dried root or rhizome for traditional bitter-tonic or liver-protectant claims. These figures apply to dried, non-standardized material and do not create a universal dose for concentrated extracts.

Crude powder: 1–3 g daily is the pharmacopoeial range; individual selection of dose, vehicle and duration belongs to clinical practice.
Older hepatitis trial: 375 mg of root powder three times daily for two weeks was the studied regimen, not a general prescription for hepatitis.
Picroliv trial product: the registered Phase III protocol uses 100 mg twice daily for 24 weeks in addition to standard care. This investigational fraction is not equivalent to ordinary Kutki capsules.

Course length is individualized; an eight-to-twelve-week default is not part of the pharmacopoeial monograph. Persistent jaundice, dark urine, pale stools, abdominal swelling, vomiting, confusion or unexplained liver-test abnormalities require prompt medical assessment.

Safety Profile and Contraindications

Safety information for Kutki is less extensive than for established medicines. Its pharmacopoeial bhedinī action and recognized laxative use are clinically relevant: loose stools or a laxative effect can occur. Health Canada advises adults to separate Kutki from other medicines or health products by a few hours and lists pregnancy, breastfeeding, fever and undiagnosed gastrointestinal trouble among situations in which the product should not be used.

Pregnancy and breastfeeding: do not use Kutki.
Children: the Health Canada monograph provides adult dosing only; pediatric use requires professional assessment.
Liver or biliary disease: do not self-treat jaundice, hepatitis, gallbladder symptoms or abnormal liver tests. Preclinical choleretic activity does not establish safety in biliary obstruction.
Medicines: a prescriber or pharmacist should review concurrent medicines, particularly treatments with a narrow therapeutic range.

Kutki Compared With Milk Thistle

A comparison is useful only when it preserves the limits of both evidence bases. Milk thistle has been tested in more human liver-disease trials, but the US National Center for Complementary and Integrative Health describes the results as conflicting or too limited for firm conclusions. Kutki has a smaller human literature and a larger proportion of preclinical work.

Parameter	Kutki	Milk Thistle
Main studied constituents	Picrosides, kutkoside and the picroliv fraction	Silymarin flavonolignans, including silybin
Human liver evidence	Very limited; one small older acute-hepatitis trial is central	More trials, but findings remain inconsistent across liver conditions
Traditional identity	Official Ayurvedic drug with dīpanī, bhedinī and jvarahara actions	Botanical used in Western herbal traditions
Conservation	Globally Endangered and included in CITES Appendix II	Not subject to the same Kutki-specific trade concern

Sustainability and Authentic Sourcing

The 2021 IUCN assessment lists Picrorhiza kurroa as Endangered and identifies overexploitation, habitat loss and destructive uprooting among the pressures on wild populations. The species is also controlled under CITES Appendix II. Ethical purchasing therefore requires more than a generic “Himalayan” label: suppliers should provide correct botanical identity, legal traceability and cultivated or otherwise demonstrably sustainable material.

Current Clinical Development

ClinicalTrials.gov lists NCT07452744, a Phase III multicentre randomized double-blind placebo-controlled study of picroliv in 170 adults with uncomplicated NAFLD. The protocol uses picroliv 100 mg twice daily plus standard care for 24 weeks, with longer follow-up. Until results are posted and independently assessed, the trial is evidence of active development rather than proof of benefit.

Kutki is an authentic Ayurvedic drug with a defined pharmacopoeial profile, substantial experimental pharmacology and limited human evidence. Responsible use means matching the preparation to the tradition or trial being cited, avoiding exaggerated liver-detox claims, choosing sustainable material and keeping medical diagnosis and standard treatment central.

Disclaimer: This article is for educational purposes and does not constitute medical advice. Consult a qualified Ayurvedic practitioner and an appropriate healthcare provider before using Kutki, especially during treatment for liver, gallbladder or gastrointestinal disease or when taking prescription medicines. Do not use Kutki or an Ayurvedic formulation as a replacement for prescribed care.